Global Phase 3 Program Expected to Commence Before End of Q3 2017 International Phase 3 Trials Entitled “ULTIMATE I” and “ULTIMATE II” to be Led by Lawrence Steinman, MD, of Stanford University NEW ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback